NX1 — Nexalis Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$2.28m
- AU$2.21m
- AU$0.99m
Australia Stock Exchange release from LIFESPOT HEALTH : Change in substantial holding
Australia Stock Exchange release from LIFESPOT HEALTH : Becoming a substantial holder
Australia Stock Exchange release from LIFESPOT HEALTH : Change in substantial holding
Australia Stock Exchange release from LIFESPOT HEALTH : Change in substantial holding
Australia Stock Exchange release from LIFESPOT HEALTH : Section 708A Notice
Australia Stock Exchange release from LIFESPOT HEALTH : Proposed issue of Securities - LSH
Australia Stock Exchange release from LIFESPOT HEALTH : Change of Directors' Interest Notices
Australia Stock Exchange release from LIFESPOT HEALTH : Appendix 2A
Lifespot Health gains on placement to fund clinical trial of inhaler devices
Australia Stock Exchange release from LIFESPOT HEALTH : 720,500 Private Placement
Australia Stock Exchange release from LIFESPOT HEALTH : PRE_NR Ends: 13:35:50
Australia Stock Exchange release from LIFESPOT HEALTH : Proposed issue of Securities - LSH
Australia Stock Exchange release from LIFESPOT HEALTH : Quarter 3 Update
Australia Stock Exchange release from LIFESPOT HEALTH : PRE_NR Ends: 10:53:12
Australia Stock Exchange release from LIFESPOT HEALTH : Appendix 4C - quarterly
Australia Stock Exchange release from LIFESPOT HEALTH : PRE_NR Ends: 10:53:08
Australia Stock Exchange release from LIFESPOT HEALTH : Pause in Trading
Brief: Lifespot Health Appoints Matthew Golden As CEO
Australia Stock Exchange release from LIFESPOT HEALTH : Ceasing to be a substantial holder